Healthcare/MedTech M&A Trends & Analysis Report Reveals Where Strategic and PE Buyers Are Deploying Capital in 2026Seattle-Tacoma, WA, ...

Johnson & Johnson MedTech (NYSE:JNJ) is enacting an organizational restructuring, changing the way its business units operate ...

AI acceleration, regulatory changes, and economic shifts promise to reshape the industry landscape amid innovation surge.

This is where real value in medtech comes to play, and that’s how companies are going to win the market. Winning requires all five pillars to be in place at once. Medtech companies can’t launch ...

MedTech microbots are an interdisciplinary deep-tech problem, a cross-section of physics, mathematics and biology.

This week in Pedersen's POV, MD+DI Senior Editor Amanda Pedersen explores the medtech industry's most pressing needs as 2025 ...

The report centers around Ireland’s position within the medtech industry as Europe’s second-largest exporter of medtech ...

"Winning the MedTech Innovator 2025 Value Award, and taking the top spot in their competition again, is a powerful validation of Wavelet's momentum," said Liz Golden, co-founder and CEO, Wavelet.

Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with its automated pump and potentially offer a longer-lasting system for people ...

Johnson & Johnson stock (NYSE: JNJ) will report its Q2 2024 results on Wednesday, July 17. We expect the company to post revenue of $22.5 billion and earnings of $2.72 per share, broadly aligning with ...

Hull-based med tech group, Smith+Nephew, has outlined a strategy intended to deliver new levels of financial and operational ...